Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report

Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report

The identification of ERBB2 (HER2) alteration in some solid tumors has become critically important due to the actionable events predictive of response to anti-HER2 therapy. However, the efficacy of ERBB2 mutated hilar cholangiocarcinoma (hCCA) against ERBB2 is rarely reported. Here we report a 76-ye...

Full description

Bibliographic Details
Main Authors: Daobing Zeng, Xiaofei Zhao, Liang Di, Luyan Lou, Yanfang Song, Yanrui Zhang, Huanhuan Liu, Guangming Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
cholangiocarcinoma
ERBB2 mutation
treatment
trastuzumab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.918297/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.918297/full

Similar Items